Unrecognized Tax Benefits of BeOne Medicines Ltd. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
BeOne Medicines Ltd. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • BeOne Medicines Ltd. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $27,835,000, a 61% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

BeOne Medicines Ltd. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $27,835,000 +$10,596,000 +61% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $22,003,000 +$4,411,000 +25% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $21,488,000 +$5,684,000 +36% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $17,575,000 +$2,651,000 +18% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $17,239,000 +$2,975,000 +21% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $17,592,000 +$3,682,000 +26% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $15,804,000 +$3,280,000 +26% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $14,924,000 +$2,959,000 +25% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $14,264,000 +$2,709,000 +23% 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $13,910,000 +$1,185,000 +9.3% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $12,524,000 +$759,000 +6.5% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $11,965,000 +$1,151,000 +11% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $11,555,000 +$1,630,000 +16% 31 Dec 2022 10-K 26 Feb 2026 2025 FY
Q3 2022 $12,725,000 +$3,641,000 +40% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $11,765,000 +$3,459,000 +42% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $10,814,000 +$3,087,000 +40% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $9,925,000 +$2,802,000 +39% 31 Dec 2021 10-K 27 Feb 2025 2024 FY
Q3 2021 $9,084,000 +$2,542,000 +39% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $8,306,000 +$2,523,000 +44% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $7,727,000 +$2,724,000 +54% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $7,123,000 +$2,490,000 +54% 31 Dec 2020 10-K 26 Feb 2024 2023 FY
Q3 2020 $6,542,000 +$3,265,000 +100% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $5,783,000 +$2,913,000 +101% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $5,003,000 +$2,444,000 +96% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $4,633,000 +$2,338,000 +102% 31 Dec 2019 10-K 27 Feb 2023 2022 FY
Q3 2019 $3,277,000 +$1,373,000 +72% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $2,870,000 +$1,318,000 +85% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $2,559,000 +$1,377,000 +116% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $2,295,000 +$1,377,000 +150% 31 Dec 2018 10-K 28 Feb 2022 2021 FY
Q3 2018 $1,904,000 +$1,270,000 +200% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 $1,552,000 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 $1,182,000 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 $918,000 +$808,000 +735% 31 Dec 2017 10-K 25 Feb 2021 2020 FY
Q3 2017 $634,000 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q4 2016 $110,000 +$110,000 31 Dec 2016 10-K 02 Mar 2020 2019 FY
Q4 2015 $0 31 Dec 2015 10-K 28 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.